CONTRACT RESEARCH & CONTRACT MANUFACTURING ORGANIZATIONS
With a busy 2017, we've compiled the biopharma partnering and M&A deal activity so far this year (through May).
Quickly see what collaborations have been forged in 2017 in the various therapeutic areas, and drill down for more detail by clicking the hyperlinks to news releases.
This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences businesses and assets. Get an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital and present value.
If you want to find ways to expand your biomedical startup using NIH funding, you won't want to miss this guide! Stephanie Fertig and Kory Hallett from the National Institutes of Health (NIH) give an overview of SBIR and STTR Small Business programs at the NIH.
GlaxoSmithKline CEO Andrew Witty once commented on the high cost of drug development, saying, “If you stop failing so often, you massively reduce the cost of drug development.”
So, why do clinical trials fail, and what can be done about it?
When entering due diligence, it's important to know what information to share and when to share it ensure a timely process. This excel-based due diligence checklist - which is easy to upload to a virtual data room - is designed to make sure you have the information you need for a streamlined due diligence process.
Gain a high-level overview of the main biopharma partnering deals of 2016, along with links to news articles relating to each deal. Quickly see what collaborations have been forged in the various therapeutic areas.
Due diligence and finance experts from global pharmaceutical companies join legal advisors and consultants to share their expertise in a lively discussion on the issues that arise during due diligence.
Using suppliers is an excellent way to get access to skills and technology that aren’t available internally. However, using suppliers may also create wasted time and effort on the part of the company and the supplier. After both working with suppliers and being a supplier, Maren Nelson has learned...